Effect of oxymatrine combined with low dose 5-Fu on lymphatic vessel and microvascular endothelial cell growth of gastric cancer in a severe combined immunodeficient mouse orthotopic implantation model

European Journal of Inflammation

Volumn 9, Issue 1, 2011, Pages 45-51

  Zhu, Jin Shui ^a   Xu, Z P ^a   Song, M Q ^a   Zhang, Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

FQ PCR; Gastric cancer; Lymphangiogenesis; Lymphatic vessel density(LVD); Oxymarine; Oxymatrine combined with low dose 5 Fu; Podoplanin; SCID; Vascular endothelial growth factor(VEGF)

Indexed keywords

FLUOROURACIL; OXYMATRINE; SODIUM CHLORIDE; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; LYMPH VESSEL; MOUSE; NONHUMAN; SEVERE COMBINED IMMUNODEFICIENCY; STOMACH CANCER;

EID: 81755176836     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900107     Document Type: Article

References (29)

1. Portera CA Jr, Berman RS, Ellis LM. Molecular determinants of gastric cancer metastasis. Surg Oncol 1998; 7:183-95.
2. Fidler IJ. Critical determinants of metastasis. Semin Cancer Biol 2002; 12:89-96. (Pubitemid 34680737)
3. Zhu JS, Sheng B, Chen JL, Chen GQ, Yu XH, Yu HF, Zhu ZM. Molecule action mechanisms of Oxymatrine combined with low dose 5-Fu on human gastric cancer SGC-7901 cells in vivo or in vitro. World J Gastroenterol 2003; 10:2366-69.
4. Zhu JS, Jiang XH, Cheng WX. Studies on peritoneal chemotherapy treatment of gastric cancer ascites and correlative effects. Hepato Gastroenterol 2000; 15:108.
5. Wang ZN, Xu HM, Jiang L, Zhou X, Lu C, Zhang X. Expression of survivin aRNA in peritoneal lavage fluid from patients with gastric cancer. Chin Med J 2004; 117:1210-17. (Pubitemid 39199929)
6. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. Laser-capture microdissection. Science 1996; 274:998-01.
7. Böhm M,Wieland I, Schütze K, Rübben H. Microbeam moment: non-contact laser microdissection of membrane-mounted native tissue. Am J Pathol 1997; 151:63-67.
8. Liotta L, Petricoin E. Molecular profiling of human cancer. Nat Rev 2000; 1:48-56.
9. Wang L, Zhu JS, Song MQ, Chen GQ, Chen JL. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 2006; 12:6949-54. (Pubitemid 44834884)
10. Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med 2004; 10:6-11. (Pubitemid 39440315)
11. Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis.J Leukoc Biol 2006; 79:639-51. (Pubitemid 44835596)
12. Cui Y, Ying Y, van Hasselt A, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE 2008; 3:e2990.
13. Ye F, Zhang SF, Xie X, Lu WG. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma. Cancer Invest 2008; 26:569-74. (Pubitemid 351918578)
14. Hayashida T, Ueda M, Aiura K, Tada H, Onizuka M, Seno M, Yamada H, Kitajima M. Anti-angiogenic effect of an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1. Protein Eng Des Sel 2005; 18:321-7. (Pubitemid 41399426)
15. Mahajan NP, Whang YE, Mohler JL, Earp HS. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor. Cancer Res 2005; 65:10514-23. (Pubitemid 41743747)
16. Lynch G, Kohler S, Leser J, Beil M, Garcia-Marin LJ, Lutz MP. The tyrosine kinase Yes regulates actin structure and secretion during pancreatic acinar cell damage in rats. Pflugers Arch 2004; 447:445-51. (Pubitemid 38141930)
17. Ntougkos E, Rush R, Scott D, Frankenberg T, Gabra H, Smyth JF, Sellar GC. The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates. Clin Cancer Res 2005; 11:5764-68. (Pubitemid 41170301)
18. Reed JE, Dunn JR, du Plessis DG, et al. Expression of cellular adhesion molecule 'OPCML' is downregulated in gliomas and other brain tumours. Neuropathol Appl Neurobiol 2007; 33:77-85. (Pubitemid 46090312)
19. Sellar GC, Watt KP, Rabiasz GJ, et al. OPCML at 11q25 is epigenetically inactivated and has tumorsuppressor function in epithelial ovarian cancer. Nat Genet 2003; 34:337-43. (Pubitemid 36792869)
20. Guo W, Shang F, Liu Q. Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation. Invest Ophthalmol Vis Sci 2004; 4:1194-01.
21. Wei W, Ayad NG, Wan Y. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004; 6979:194-8. (Pubitemid 38374317)
22. Kudo Y, Kitajima S, Sato S. Transfection of p27(Kip 1) threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells. Oncology 2002; 4:398-404. (Pubitemid 36151534)
23. Defatta RJ, De Benedetti A. Translational upregulation of Yes accompanies eIF4E-mediated oncogenic transformation. Int J Oncol 2000; 23:1709-13.
24. Lawson C, Goupil S, Leclerc P. Increased activity of the human sperm tyrosine kinase src by the camp-dependent pathway in the presence of calcium. Biol Reprod 2008; 79:657-66.
25. Barraclough J, Hodgkinson C, Hogg A, Dive C, Welman A. Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells. Neoplasia 2007; 9:745-54. (Pubitemid 47523236)
26. Mahajan NP, Liu Y, Majumder S, Warren MR, Parker CE, Mohler JL, Earp HS, Whang YE. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci 2007; 104:8438-43. (Pubitemid 47175506)
27. Modzelewska K, Newman LP, Desai R, Keely PJ. Ackl mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem 2006; 281:37527-35. (Pubitemid 46042056)
28. Castiglione F, Taddei A, Buccoliero AM, Garbini F, Gheri CF, Freschi G, Bechi P, Degl'Innocenti DR, Taddei GL. TNM staging and T-cell receptor gamma expression in gastric adenocarcinoma. Correlation with disease progression? Tumori 2008; 94:384-88.
29. Iddings D, Bilchik A. The biologic significance of micrometastatic disease and sentinel lymph node technology on colorectal cancer. J Surg Oncol 2007; 96:671-7.